Barzegar, M., Houshi, S., Sadeghi, E., Hashemi, M. S., Pishgahi, G., Bagherieh, S., . . . Zabeti, A. (2022). Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis. Multiple sclerosis international, 2022, 1-13. https://doi.org/10.1155/2022/9388813
Chicago-Zitierstil (17. Ausg.)Barzegar, Mahdi, et al. "Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis." Multiple Sclerosis International 2022 (2022): 1-13. https://doi.org/10.1155/2022/9388813.
MLA-Zitierstil (9. Ausg.)Barzegar, Mahdi, et al. "Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis." Multiple Sclerosis International, vol. 2022, 2022, pp. 1-13, https://doi.org/10.1155/2022/9388813.